MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A Post-mortem Study on Striatal Glia and Blood Brain Barrier Integrity in Aging and PD Asian-Indians.

    H J. Jyothi, A. Mahadevan, U. Muthane, T C. Yasha, P. Alladi (Bengaluru, India)

    Objective: We examined the glial and blood brain barrier (BBB) changes related to normal aging and PD in the Asian-Indian striatum. Background: increases the risk…
  • 2024 International Congress

    Late-onset neurologic Wilson’s disease: case series

    I. Minaev, E. Nuzhnyi, V. Poleschuk, A. Protopopova, N. Abramycheva, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To report the case series of patients with late-onset Wilson’s disease (WD) with predominantly neurological manifestation. Background: WD is a rare and treatable disorder…
  • 2024 International Congress

    Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

    Objective: Idiopathic Parkinson's disease (PD) and Normal pressure hydrocephalus (NPH) can have similar clinical presentation. However, diagnostic precision is important as clinical management differs. Previous…
  • 2024 International Congress

    PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago.

    J. Deliz, E. Espinoza, S. Kola, E. Zivin, K. Williams, J. Adrissi, P. Gonzalez-Latapi, D. Larson (Chicago, USA)

    Objective: To employ a community-based participatory research (CBPR) approach in developing and testing a workshop-based, peer-led intervention aimed at increasing PD awareness among youth and…
  • 2024 International Congress

    Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson’s disease, multiple system atrophy, and cerebellar ataxia

    B. Jin, H. Kim, K. Woo, J. Shin (Seoul, Republic of Korea)

    Objective: To analyze syllable-based speech characteristics in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), and cerebellar ataxia (CA) to determine if there is…
  • 2024 International Congress

    Correlation of lmaging Markers with Clinical Features in Multiple System Atrophy Patients

    N. Jin (Hangzhou, China)

    Objective: This study aims to investigate the correlation between visually assessable imaging markers and their clinical symptoms in Multiple System Atrophy (MSA) patients. Background: MSA is…
  • 2024 International Congress

    Tau Deposition in Locus Coeruleus is Associated with Rapid Eye Movement Sleep Behavior Disorder in Progressive Supranuclear Palsy.

    X. Li, FT. Liu (Shanghai, China)

    Objective: In this study, we aimed to investigate the frequency of Rapid eye movement sleep behavior disorder (RBD) occurring in a large cohort of PSP,…
  • 2024 International Congress

    Peripheral inflammation severity in differential diagnosis of progressive supranuclear palsy and multiple system atrophy – usefulness of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and neutrophil-to-high-density lipoprotein-cholesterol ratio

    N. Madetko-Alster, B. Migda, P. Chunowski, P. Alster (Warsaw, Poland)

    Objective: Assessment of the possible differences in peripheral inflammation severity between progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) with the use of three…
  • 2024 International Congress

    PSP: a Clinical Case

    K. Manysheva, D. Makhmudova (Makhachkala, Russian Federation)

    Objective: PSP is traditionally considered a neurodegenerative disease of late life. Its diagnostic criteria include the item “age of onset over 40 years.” This significantly…
  • 2024 International Congress

    α-Synuclein Seed Amplification Assay Amplification Parameters and Progression in Parkinson’s Disease

    D. Coughlin, B. Shifflett, A. Siderowf, S. Edland, D. Galasko, C. Farris, Y. Ma, C. Soto, L. Concha-Marambio (San Diego, USA)

    Objective: To examine the relationship between the reaction parameters of the cerebrospinal fluid (CSF) αSyn seed amplification assay (αSyn-SAA) to the risk of developing motor…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley